Variant report

Variant	esv3423490
Chromosome Location	chr6:132127884-132130632
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:326)
CpG islands
(count:793)
Chromatin interactive
region (count:6)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:326 , 50 per page) page: 1 2 3 4 5 6 7

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:132128708-132128994	HepG2	liver:	n/a	n/a
2	BACH1	chr6:132128627-132129037	H1-hESC	embryonic stem cell:	n/a	n/a
3	BHLHE40	chr6:132128841-132129008	K562	blood:	n/a	n/a
4	BRCA1	chr6:132128815-132128946	HepG2	liver:	n/a	n/a
5	CCNT2	chr6:132129245-132129625	K562	blood:	n/a	n/a
6	CEBPB	chr6:132129932-132130450	A549	lung:	n/a	n/a
7	CEBPB	chr6:132129959-132130318	MCF-7	breast:	n/a	n/a
8	CEBPB	chr6:132129959-132130348	HepG2	liver:	n/a	n/a
9	CEBPB	chr6:132130043-132130380	IMR90	lung:	n/a	n/a
10	CEBPB	chr6:132128827-132128835	H1-hESC	embryonic stem cell:	n/a	n/a
11	CEBPB	chr6:132130008-132130389	HepG2	liver:	n/a	n/a
12	CEBPB	chr6:132130045-132130337	H1-hESC	embryonic stem cell:	n/a	n/a
13	CEBPB	chr6:132128724-132128863	HepG2	liver:	n/a	n/a
14	CEBPB	chr6:132130042-132130401	ECC-1	luminal epithelium:	n/a	n/a
15	CEBPB	chr6:132130046-132130348	K562	blood:	n/a	n/a
16	CEBPB	chr6:132130052-132130318	HepG2	liver:	n/a	n/a
17	CEBPD	chr6:132128649-132129409	HepG2	liver:	n/a	n/a
18	CEBPD	chr6:132129083-132129365	HepG2	liver:	n/a	n/a
19	CHD1	chr6:132128642-132128830	H1-hESC	embryonic stem cell:	n/a	n/a
20	CHD2	chr6:132128669-132129042	HepG2	liver:	n/a	chr6:132128900-132128910
21	CHD2	chr6:132129327-132129618	HepG2	liver:	n/a	n/a
22	CHD2	chr6:132128856-132129049	Hela-S3	cervix:	n/a	chr6:132128900-132128910
23	CHD2	chr6:132128647-132128833	H1-hESC	embryonic stem cell:	n/a	n/a
24	CREB1	chr6:132129136-132129371	A549	lung:	n/a	n/a
25	CREB1	chr6:132128465-132129850	HepG2	liver:	n/a	n/a
26	CREB1	chr6:132128684-132129055	A549	lung:	n/a	n/a
27	CTBP2	chr6:132128580-132129756	H1-hESC	embryonic stem cell:	n/a	n/a
28	CTCF	chr6:132128705-132128933	ProgFib	skin:	n/a	n/a
29	CTCF	chr6:132128780-132128930	HepG2	liver:	n/a	n/a
30	CTCF	chr6:132128880-132129030	HRE	kidney:	n/a	n/a
31	CTCF	chr6:132128760-132128910	Caco-2	colon:	n/a	n/a
32	CTCF	chr6:132128623-132128941	K562	blood:	n/a	n/a
33	CTCF	chr6:132128700-132128850	SK-N-SH_RA	brain:	n/a	n/a
34	CTCF	chr6:132128680-132128830	HCT-116	colon:	n/a	n/a
35	CTCF	chr6:132128700-132128850	GM06990	blood:	n/a	n/a
36	CTCF	chr6:132128720-132128870	HCPEpiC	choroid plexus:	n/a	n/a
37	CTCF	chr6:132128760-132128910	GM06990	blood:	n/a	n/a
38	CTCF	chr6:132128720-132128870	GM12868	blood:	n/a	n/a
39	CTCF	chr6:132128520-132128670	A549	lung:	n/a	n/a
40	CTCF	chr6:132128780-132128930	GM12873	blood:	n/a	n/a
41	CTCF	chr6:132128680-132128830	GM12871	blood:	n/a	n/a
42	CTCF	chr6:132128698-132128920	A549	lung:	n/a	n/a
43	CTCF	chr6:132128780-132128930	HMF	breast:	n/a	n/a
44	CTCF	chr6:132128689-132128941	MCF-7	breast:	n/a	n/a
45	CTCF	chr6:132128760-132128910	AG04450	lung:	n/a	n/a
46	CTCF	chr6:132128720-132128870	WERI-Rb-1	eye:	n/a	n/a
47	CTCF	chr6:132128700-132128850	AoAF	blood vessel:	n/a	n/a
48	CTCF	chr6:132128760-132128910	HBMEC	blood vessel:	n/a	n/a
49	CTCF	chr6:132128680-132128830	HPAF	blood vessel:	n/a	n/a
50	CTCF	chr6:132128680-132128830	HRPEpiC	eye:	n/a	n/a

(count:793 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:132129013-132129063	HL-60	blood:	n/a
2	chr6:132129008-132129058	SK-N-SH_RA	brain:	n/a
3	chr6:132129103-132129153	HCT-116	colon:	n/a
4	chr6:132129590-132129640	GM19239	blood:	n/a
5	chr6:132129044-132129094	GM12892	blood:	n/a
6	chr6:132129037-132129087	ProgFib	skin:	n/a
7	chr6:132129363-132129413	AG09309	skin:	n/a
8	chr6:132129037-132129087	HUVEC	blood vessel:	n/a
9	chr6:132128337-132128387	AG04450	lung:	fetal
10	chr6:132129021-132129071	ProgFib	skin:	n/a
11	chr6:132128915-132128965	HMEC	breast:	n/a
12	chr6:132129037-132129087	HPAEpiC	pulmonary alveolar:	n/a
13	chr6:132129423-132129473	A549	lung:	n/a
14	chr6:132128965-132129015	K562	blood:	n/a
15	chr6:132129021-132129071	HepG2	liver:	n/a
16	chr6:132129423-132129473	GM12892	blood:	n/a
17	chr6:132128915-132128965	MCF10A-Er-Src	breast:	n/a
18	chr6:132129021-132129071	MCF-7	breast:	n/a
19	chr6:132129021-132129071	AG10803	skin:	n/a
20	chr6:132128915-132128965	HL-60	blood:	n/a
21	chr6:132128965-132129015	GM12892	blood:	n/a
22	chr6:132129021-132129071	A549	lung:	n/a
23	chr6:132129044-132129094	A549	lung:	n/a
24	chr6:132129423-132129473	NHDF-neo	bronchial:	n/a
25	chr6:132128915-132128965	IMR90	lung:	fetal
26	chr6:132128945-132128995	HMEC	breast:	n/a
27	chr6:132129013-132129063	BE2_C	brain:	n/a
28	chr6:132129590-132129640	AG04449	skin:	fetal
29	chr6:132129103-132129153	HNPCEpiC	eye:	n/a
30	chr6:132128337-132128387	BJ	skin:	n/a
31	chr6:132129103-132129153	T-47D	breast:	n/a
32	chr6:132129103-132129153	ProgFib	skin:	n/a
33	chr6:132129008-132129058	GM19239	blood:	n/a
34	chr6:132129013-132129063	GM19239	blood:	n/a
35	chr6:132129363-132129413	PrEC	prostate:	n/a
36	chr6:132129008-132129058	HEK293	kidney:	embryo
37	chr6:132128915-132128965	GM19239	blood:	n/a
38	chr6:132129590-132129640	HNPCEpiC	eye:	n/a
39	chr6:132128965-132129015	GM12878	blood:	n/a
40	chr6:132129103-132129153	Hepatocyte	liver:	n/a
41	chr6:132128945-132128995	HRPEpiC	eye:	n/a
42	chr6:132129044-132129094	BE2_C	brain:	n/a
43	chr6:132128337-132128387	Hela-S3	cervix:	n/a
44	chr6:132128915-132128965	U87	brain:	n/a
45	chr6:132129423-132129473	CMK	blood:	n/a
46	chr6:132129363-132129413	HEK293	kidney:	embryo
47	chr6:132128337-132128387	HUVEC	blood vessel:	n/a
48	chr6:132128965-132129015	Hela-S3	cervix:	n/a
49	chr6:132129423-132129473	ProgFib	skin:	n/a
50	chr6:132129008-132129058	HRCEpiC	kidney:	n/a

(count:6 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:132128149..132132112-chr6:132147030..132152072,5	MCF-7	breast:
2	chr6:132127756..132130246-chr6:132148008..132150797,2	MCF-7	breast:
3	chr6:132127914..132130474-chr8:77911866..77914153,2	MCF-7	breast:
4	chr6:132126867..132133246-chr6:132138030..132146402,10	MCF-7	breast:
5	chr6:132129754..132131515-chr6:132134330..132136178,2	K562	blood:
6	chr6:132126588..132131688-chr6:132138399..132143000,6	MCF-7	breast:

No data

Variant related genes	Relation type
ENPP1	TF binding region
ENPP1	CpG island
ENSG00000219532	chromatin interactions
ENSG00000164751	chromatin interactions
ENSG00000237115	chromatin interactions
ENSG00000200895	chromatin interactions

Extended variants
information (count: 76 )
Associated
traits (count: 78 )

Variant overlapped rSNPs/rCNVs (count:76 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs576711101	chr6:132127888-132127889	Bivalent Enhancer Enhancers Weak transcription Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
2	rs188257705	chr6:132127892-132127893	Bivalent Enhancer Enhancers Weak transcription Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
3	rs193168367	chr6:132127894-132127895	Bivalent Enhancer Enhancers Weak transcription Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
4	rs569431330	chr6:132127900-132127901	Bivalent Enhancer Enhancers Weak transcription Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
5	rs530218832	chr6:132127918-132127919	Bivalent Enhancer Enhancers Weak transcription Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
6	rs548675081	chr6:132127960-132127961	Bivalent Enhancer Enhancers Weak transcription Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
7	rs544087287	chr6:132127973-132127974	Bivalent Enhancer Enhancers Weak transcription Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
8	rs112019763	chr6:132128021-132128022	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
9	rs558892432	chr6:132128038-132128039	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
10	rs570702879	chr6:132128048-132128049	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
11	rs537739237	chr6:132128064-132128065	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
12	rs533122513	chr6:132128072-132128073	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
13	rs79433545	chr6:132128149-132128150	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
14	rs541539735	chr6:132128337-132128338	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
15	rs147119327	chr6:132128355-132128356	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
16	rs118060938	chr6:132128401-132128402	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
17	rs565456449	chr6:132128409-132128410	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
18	rs114654889	chr6:132128482-132128483	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
19	rs76126676	chr6:132128551-132128552	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
20	rs1800949	chr6:132128564-132128565	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
21	rs184594580	chr6:132128608-132128609	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
22	rs187033293	chr6:132128625-132128626	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
23	rs70961711	chr6:132128629-132128630	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
24	rs541095105	chr6:132128648-132128649	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
25	rs137869236	chr6:132128705-132128706	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
26	rs563099009	chr6:132128774-132128775	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
27	rs530284718	chr6:132128778-132128779	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
28	rs548750156	chr6:132128780-132128781	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
29	rs566883106	chr6:132128787-132128788	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
30	rs115872950	chr6:132128840-132128841	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
31	rs552330579	chr6:132128852-132128853	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
32	rs570473996	chr6:132128869-132128870	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
33	rs1799773	chr6:132128879-132128880	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
34	rs191877795	chr6:132128908-132128909	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
35	rs372062402	chr6:132128933-132128934	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
36	rs183601308	chr6:132128972-132128973	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
37	rs13211147	chr6:132129078-132129079	Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
38	rs13211159	chr6:132129092-132129093	Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
39	rs13211165	chr6:132129106-132129107	Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
40	rs188291420	chr6:132129141-132129142	Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
41	rs12212106	chr6:132129144-132129145	Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
42	rs1800948	chr6:132129152-132129153	Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
43	rs535293574	chr6:132129163-132129164	Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
44	rs28620420	chr6:132129236-132129237	Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
45	rs553929139	chr6:132129295-132129296	Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
46	rs200362492	chr6:132129363-132129364	Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
47	rs572083019	chr6:132129386-132129387	Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
48	rs545840805	chr6:132129524-132129525	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
49	rs13214646	chr6:132129595-132129596	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
50	rs111798087	chr6:132129703-132129704	Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:78)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Autism	22495311	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Colorectal cancer	16272173	CNVD
Gastric cancer	17908304	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Ependymoma	16718352	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Prostate cancer	18632612	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Glioma	21046410	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Zellweger syndrome	21572526	CNVD
Follicular lymphoma	20505157	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Lung adenocarcinoma	21935476	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Chondromyxoid Fibroma	20696777	CNVD
Cancer	21183584	CNVD
Developmental delay	19490664	CNVD
Non-muscle invasive bladder neoplasm	19445696	CNVD
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	21785460	CNVD
Kartagener syndrome	16639409	CNVD
Breast cancer	17133270	CNVD
Follicular lymphoma	18703704	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
Breast cancer	21364760	CNVD
Myelofibrosis	22110671	CNVD
Renal cell carcinoma	18592004	CNVD

Chromatin state (count:461 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:132124800-132128200	Weak transcription	Stomach Mucosa	stomach
2	chr6:132124800-132128400	Weak transcription	Primary T helper naive cells from peripheral blood	blood
3	chr6:132124800-132128400	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
4	chr6:132124800-132128400	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
5	chr6:132125000-132128200	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
6	chr6:132125000-132128200	Weak transcription	Fetal Stomach	stomach
7	chr6:132126200-132128400	Enhancers	Breast Myoepithelial Primary Cells	Breast
8	chr6:132126600-132128400	Weak transcription	Ovary	ovary
9	chr6:132126800-132128200	Enhancers	HepG2	liver
10	chr6:132127000-132128200	Weak transcription	Fetal Kidney	kidney
11	chr6:132127400-132128000	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
12	chr6:132127400-132128200	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
13	chr6:132127600-132128000	Weak transcription	Liver	Liver
14	chr6:132127600-132128200	Active TSS	Primary T helper 17 cells PMA-I stimulated	--
15	chr6:132127600-132128200	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
16	chr6:132127800-132128000	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
17	chr6:132127800-132128200	Enhancers	NHDF-Ad	bronchial
18	chr6:132127800-132128200	Enhancers	Osteobl	bone
19	chr6:132128000-132128200	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
20	chr6:132128000-132128200	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
21	chr6:132128000-132128200	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
22	chr6:132128000-132128200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
23	chr6:132128000-132128200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
24	chr6:132128000-132128200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
25	chr6:132128000-132128200	Enhancers	Adipose Nuclei	Adipose
26	chr6:132128000-132128200	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
27	chr6:132128000-132128200	Enhancers	Duodenum Mucosa	Duodenum
28	chr6:132128000-132128200	Enhancers	Skeletal Muscle Male	skeletal muscle
29	chr6:132128000-132128200	Enhancers	HSMMtube	muscle
30	chr6:132128000-132128200	Enhancers	NH-A	brain
31	chr6:132128000-132128200	Enhancers	NHLF	lung
32	chr6:132128000-132128400	Enhancers	Liver	Liver
33	chr6:132128000-132128600	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
34	chr6:132128000-132130400	Active TSS	Pancreatic Islets	Pancreatic Islet
35	chr6:132128200-132128400	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
36	chr6:132128200-132128400	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
37	chr6:132128200-132128400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
38	chr6:132128200-132128400	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
39	chr6:132128200-132128400	Bivalent/Poised TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
40	chr6:132128200-132128400	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
41	chr6:132128200-132128400	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
42	chr6:132128200-132128400	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
43	chr6:132128200-132128400	Flanking Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
44	chr6:132128200-132128400	Enhancers	Primary B cells from peripheral blood	blood
45	chr6:132128200-132128400	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
46	chr6:132128200-132128400	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
47	chr6:132128200-132128400	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
48	chr6:132128200-132128400	Enhancers	Primary T helper cells fromperipheralblood	blood
49	chr6:132128200-132128400	Enhancers	Primary T killer naive cells fromperipheralblood	blood
50	chr6:132128200-132128400	Enhancers	Primary T killer memory cells from peripheral blood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links